{
    "id": 26326,
    "fullName": "ERBB2 G778_S779insCPG",
    "impact": "insertion",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "ERBB2 (HER2) G778_S779insCPG results in the insertion of three amino acids in the protein kinase domain of the Erbb2 (Her2) protein between amino acids 778 and 779 (UniProt.org). G778_S779insCPG is transforming in culture (PMID: 28363995), and based on the effects of other ERBB2 (HER2) exon 20 insertions (PMID: 16843263, PMID: 17311002), is predicted to result in a gain of Erbb2 (Her2) function.",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 2004,
                    "pubMedId": 16843263,
                    "title": "HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/16843263"
                },
                {
                    "id": 8567,
                    "pubMedId": 28363995,
                    "title": "Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 Inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28363995"
                },
                {
                    "id": 2002,
                    "pubMedId": 17311002,
                    "title": "The major lung cancer-derived mutants of ERBB2 are oncogenic and are associated with sensitivity to the irreversible EGFR/ERBB2 inhibitor HKI-272.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/17311002"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2064,
        "geneSymbol": "ERBB2",
        "terms": [
            "ERBB2",
            "CD340",
            "HER-2",
            "HER-2/neu",
            "HER2",
            "MLN 19",
            "NEU",
            "NGL",
            "TKR1"
        ]
    },
    "variant": "G778_S779insCPG",
    "createDate": "04/13/2017",
    "updateDate": "04/13/2017",
    "referenceTranscriptCoordinates": {
        "id": 170526,
        "transcript": "NM_004448",
        "gDna": "chr17:g.39724753_39724754insGTCCTGGTT",
        "cDna": "c.2335_2336insGTCCTGGTT",
        "protein": "p.G778_S779insCPG",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 10526,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Vizimpro (dacomitinib) inhibited growth of transformed cells expressing ERBB2 (HER2) G778_S779insCPG in culture (PMID: 28363995).",
            "molecularProfile": {
                "id": 27531,
                "profileName": "ERBB2 G778_S779insCPG"
            },
            "therapy": {
                "id": 714,
                "therapyName": "Dacomitinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 8567,
                    "pubMedId": 28363995,
                    "title": "Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 Inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28363995"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27531,
            "profileName": "ERBB2 G778_S779insCPG",
            "profileTreatmentApproaches": [
                {
                    "id": 11198,
                    "name": "HER2 Inhibitor",
                    "profileName": "ERBB2 G778_S779insCPG"
                },
                {
                    "id": 11197,
                    "name": "HER inhibitor (Pan)",
                    "profileName": "ERBB2 G778_S779insCPG"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 170526,
            "transcript": "NM_004448",
            "gDna": "chr17:g.39724753_39724754insGTCCTGGTT",
            "cDna": "c.2335_2336insGTCCTGGTT",
            "protein": "p.G778_S779insCPG",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 170527,
            "transcript": "NM_001289937",
            "gDna": "chr17:g.39724753_39724754insGTCCTGGTT",
            "cDna": "c.2335_2336insGTCCTGGTT",
            "protein": "p.G778_S779insCPG",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}